Seminar on choreas (Q36510210)

14 August 2017

1 reference

title

Seminar on choreas (English)

1 reference

14 August 2017

0 references

5

Werner Poewe

1 reference

14 August 2017

4

Gregor K Wenning

1 reference

14 August 2017

2

Klaus Seppi

1 reference

14 August 2017

3

Katherina J Mair

1 reference

14 August 2017

Francisco Cardoso

1

1 reference

14 August 2017

1 July 2006

1 reference

14 August 2017

1 reference

14 August 2017

5

1 reference

14 August 2017

7

1 reference

14 August 2017

589-602

1 reference

History of movement disorders as a neurological specialty: Part 14 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Primate models of movement disorders of basal ganglia origin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

The Basal Ganglia and involuntary movements: impaired inhibition of competing motor patterns

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Bilateral globus pallidus stimulation for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Selective sparing of a class of striatal neurons in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Diagnosis of Huntington Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Predictive DNA-testing for Huntington's disease and reproductive decision making: a European collaborative study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Incidence and prevalence of Huntington's disease in Olmsted County, Minnesota (1950 through 1989).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

DNA analysis of Huntington's disease: five years of experience in Germany, Austria, and Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Trinucleotide repeat length instability and age of onset in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Abnormal ocular motor control in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Adult onset myoclonic Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Tourettism associated with Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Bruxism in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Psychiatric syndromes in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Huntington's disease: update and review of neuropsychiatric aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Increased rate of suicide among patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Psychopathology in Huntington's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Neuropsychiatry of Huntington's disease and other basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Profile of cognitive progression in early Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Executive and mnemonic functions in early Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Progression of symptoms in the early and middle stages of Huntington disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Causes of death in patients with Huntington's disease and in unaffected first degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Conditions associated with Huntington's disease at death. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Huntington's disease: present treatments and future therapeutic modalities

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Riluzole in Huntington's disease (HD): an open label study with one year follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Dosage effects of riluzole in Huntington's disease: a multicenter placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Effects of rivastigmine on motor and cognitive impairment in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Rivastigmine in the treatment of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

CAG/CTG repeat expansions at the Huntington's disease-like 2 locus are rare in Huntington's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Clinical and genetic heterogeneity in benign hereditary chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Neuroacanthocytosis: new developments in a neglected group of dementing disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Huntington's Disease-like 2 (HDL2) in North America and Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Molecular and clinical findings in a family with dentatorubral-pallidoluysian atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Clinical aspects of CAG repeat diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

1 reference

7 January 2021

Spectrum of movement disorders in neuroferritinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

New autosomal recessive cerebellar ataxias with oculomotor apraxia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Prognostic factors in patients presenting with severe neurological forms of Wilson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Familial (idiopathic) paroxysmal dyskinesias: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Mutations in TITF-1 are associated with benign hereditary chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Huntington's disease--like 2 can present as chorea-acanthocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Huntington disease phenocopy is a familial prion disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Phenotypic features of Huntington's disease-like 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

The neuropathology of CAG repeat diseases: review and update of genetic and molecular features

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Autosomal dominant spinocerebellar ataxias: an Asian perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Wilson's disease: diagnostic errors and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Chorea in fifty consecutive patients with rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Resurgence of rheumatic fever in the United States. The changing picture of a preventable illness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Rheumatic Fever in children under 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Sydenham chorea: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham chorea.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Serum from Sydenham's chorea patients modifies intracellular calcium levels in PC12 cells by a complement-independent mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Persistent Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Sydenham's chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Sydenham's chorea may be a risk factor for drug induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Treatment of Sydenham chorea with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Sydenham Chorea in Children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Huntington's disease and other choreas.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Unusual manifestations of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Paraneoplastic limbic encephalitis (PLE) and chorea associated with CRMP-5 neuronal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

[Chorea-athetosis in the anti-Hu syndrome]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Cause and course in a series of patients with sporadic chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Hemichorea: a rare presentation of tuberculoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Chorea as a presenting feature of variant Creutzfeldt-Jakob disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Oral contraceptive induced chorea: another condition associated with anti-basal ganglia antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Low-dose L-dopa therapy in Parkinson's disease: a 6-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Neurologic approach to drug-induced movement disorders: a study of 125 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Paroxetine-induced chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Complex movement disorders induced by fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Phenytoin and dyskinesias: a report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Carbamazepine-induced choreoathetoid dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Anticonvulsants-induced chorea: a role for pharmacodynamic drug interaction?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Pemoline induced acute choreoathetosis: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Amphetamine-induced chorea in attention deficit-hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Posteroventral pallidotomy in medically intractable postapoplectic monochorea: case report.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Moyamoya‐induced paroxysmal dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Chorea after cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Primary CNS lymphoma presenting as a choreic movement disorder followed by segmental dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Chronic acquired hepatocerebral degeneration: case reports and new insights.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Diffusion-weighted and gradient echo magnetic resonance findings of hemichorea-hemiballismus associated with diabetic hyperglycemia: a hyperviscosity syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Hemiballism-hemichorea and non-ketotic hyperglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Bilateral chorea-ballism associated with hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Hereditary causes of chorea in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Drug-induced movement disorders in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Genetics of pediatric movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Gametic but not somatic instability of CAG repeat length in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

State of the art review: molecular diagnosis of inherited movement disorders. Movement Disorders Society task force on molecular diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Testing for acanthocytosis A prospective reader-blinded study in movement disorder patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart As

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Persistent chorea triggered by hyperglycemic crisis in diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Diagnostic role of 99mTc hexamethyl-propyleneamine oxime brain single photon emission computed tomography in Sydenham's chorea.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Evidence of thalamic disinhibition in patients with hemichorea: semiquantitative analysis using SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Tetrabenazine treatment for Huntington's disease-associated chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Tetrabenazine in the treatment of severe pediatric chorea.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

A randomized trial of amantadine in Huntington disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Sydenham's chorea-clinical characteristics of nine patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Treatment of post-traumatic choreo-athetosis with sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Valproate sodium in postanoxic choreoathetosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Hemiballismus treated with sodium valproate.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Inconsistent response to divalproex sodium in hemichorea/hemiballism.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Neuropsychiatric Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Randomized double-blind study with prednisone in Sydenham's chorea.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Chronic stimulation of the globus pallidus internus for treatment of non-DYT1 generalized dystonia and choreoathetosis: 2-year follow up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Senile chorea treated by deep brain stimulation: a clinical, neurophysiological and functional imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Pallidotomy for severe generalized chorea of juvenile-onset dentatorubral-pallidoluysian atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Internal globus pallidotomy in dystonia secondary to Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970494-X

7 January 2021

10.1016/S1474-4422(06)70494-X

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oehl7dvh3zc3lcmxk33yfwjwxe

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_oehl7dvh3zc3lcmxk33yfwjwxe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oehl7dvh3zc3lcmxk33yfwjwxe

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/oehl7dvh3zc3lcmxk33yfwjwxe

30 July 2022